Entero Healthcare Solutions working capital

·Consumer ServicesChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
46.36×46.36×42.80×38.99×
56.56×56.56×51.78×52.59×
34.66×34.66×24.83×23.50×
68.26×68.26×69.75×68.08×
7.79×7.20×4.14×2.78×
2.09×2.09×2.02×2.15×
0.66×0.66×−0.72×−0.92×
0.36×0.36×−0.45×−0.33×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ENTERO₹1,559.30

Entero Healthcare Solutions Ltd.

· Consumer Services
₹ CrorePeersMEDPLUSEMILCRIZACGPPLCMSINFOHEMIPROPBLACKBUCKINOXGREENMcap ₹6,785 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)—38.9942.8046.3646.36
Receivable Days (DSO)—52.5951.7856.5656.56
Payable Days (DPO)—23.5024.8334.6634.66
Cash Conversion Cycle (days)—68.0869.7568.2668.26
Working Capital Turnover—2.784.147.207.79
Asset Turnover—2.152.022.092.09
Cash Conversion (CFO/Net Income)—-0.92-0.720.660.66
CFO/EBITDA—-0.33-0.450.360.36
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.